Evaluation of the Efficacy of the Hospital Glycemic Management System for Patients with Malignant Tumors and Hyperglycemia

Juan Jiang,* Danlan Pu,* Renzhi Hu, Mingyang Hu, Qinan Wu Department of Endocrinology and Nephrology, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, 400030, People’s Republic of China*These authors contributed equally to this workCorrespondence: Qinan WuDepartment of Endocrinology and Nephrology, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, People’s Republic of ChinaEmail wqn11@126.comObjective: To explore the efficacy of the hospital glycemic management system with information integration in patients with malignant tumors and hyperglycemia.Methods: Three hundred ninety-three patients diagnosed with malignant tumors with hyperglycemia and hospitalized in the non-endocrinology department of a specialized cancer hospital from March 2019 to November 2020 were recruited. All the patients were diagnosed and treated according to the clinical department and disease course. In total, 196 patients were divided into the control group, who received the conventional blood glucose management mode, and 197 patients were divided into the intervention group, who received the hospital glycemic management system with information integration. The average daily glucose levels were recorded before and after breakfast, lunch, and dinner, at bedtime and at night. The average glucose level, glucose compliance rate, hypoglycemia rate, hyperglycemia rate, glucose measurements per day, average number of hospitalization days and patient satisfaction were compared between the groups.Results: In the intervention group, the average glucose level was significantly lower than that in the control group (P< 0.05). The hyperglycemia and hypoglycemia rates in the intervention group were lower than those in the control group (P< 0.05). The glucose compliance rate in the intervention group was higher than that in the control group (P< 0.05). The highest blood glucose level in the intervention group was lower than that in the control group (P< 0.05), and the lowest blood glucose level was higher than that in the control group (P< 0.05). The glucose measurements per day in the intervention group were higher than those in the control group, and the average number of hospitalization days in the intervention group was lower than that in the control group (P< 0.05). Patient satisfaction in the intervention group was higher than that in the control group (P< 0.05).Conclusion: The hospital glycemic management system with information integration significantly improved the glycemic management of patients with malignant non-endocrine tumors and hyperglycemia, including their glucose level and glucose compliance rate, as well as patient satisfaction, and reduced the average number of hospitalization days and risk of hyperglycemia/hypoglycemia.Keywords: information integration, malignant tumor with hyperglycemia, hospital glycemic management system